Characterization of [125I]SCH 23982 binding in human brain: comparison with [3H]SCH 23390

Neurosci Lett. 1991 Oct 14;131(2):273-6. doi: 10.1016/0304-3940(91)90631-3.

Abstract

We studied binding of [125I]SCH 23982 in two regions of human brain, the caudate and the dorsolateral prefrontal cortex. Binding characteristics of [125I]SCH 23982 and of the non-iodinated tritiated analogue, [3H]SCH 23390, were compared. In caudate, binding of [125I]SCH 23982 was consistent with binding to D1 dopamine receptors while in frontal cortex, [125I]SCH 23982 bound mostly to serotonergic 5HT2 receptors. In contrast to [3H]SCH 23390, no evidence of binding of [125I]SCH 23982 to D1 receptors could be found in human frontal cortex. This indicates that iodination of SCH 23390 induces a decrease in its relative D1 versus 5HT2 selectivity that prohibits the use of [125I]SCH 23982 to label D1 receptors in human cortex.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Benzazepines / analogs & derivatives*
  • Benzazepines / metabolism*
  • Brain / metabolism*
  • Caudate Nucleus / drug effects
  • Caudate Nucleus / metabolism
  • Cerebral Cortex / metabolism
  • Humans
  • In Vitro Techniques
  • Ketanserin / pharmacology
  • Male
  • Middle Aged
  • Receptors, Dopamine / metabolism
  • Receptors, Dopamine D1

Substances

  • 8-iodo-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3-benzazepine-7-ol
  • Benzazepines
  • Receptors, Dopamine
  • Receptors, Dopamine D1
  • Ketanserin